Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

Presentation LINC 2019

Femoral Popliteal DVT

Presenter: Robert Lookstein

January 25, 2019

Presentation

12-Month Results From First-in-Human Randomized Study of Ranger DCB for Femoropopliteal Treatment

May 08, 2018

Presentation ACC 2018

High Rate of Amputation and Death after Major Adverse Limb Events (MALE) in Peripheral Artery Disease: Results from COMPASS

Presenter: Sonia S. Anand

March 11, 2018

Presentation VIVA 2017

Two-year Results from the IN.PACT Global Study

Presenter: Thomas Zeller

September 14, 2017

Presentation VIVA 2017

Paclitaxel-Eluting Stent Treatment for PAD: Insights from the Zilver PTX Post-Market Study in Japan

Presenter: Michael Dake

September 14, 2017

Presentation CCVVC 2016

Use of Drug Eluting Stents in the SFA: What are the Current Data, Real World Applications, Upcoming Trials

Presenter: Tyrone Collins

June 15, 2016

Presentation CCVVC 2016

My most difficult femoropopliteal case: 69 yo female

Presenter: Jos C. van den Berg

June 15, 2016

Presentation CCVVC 2016

My Most Difficult Femoropopliteal Case

Presenter: Fabrizio Fanelli

June 15, 2016

Presentation Aortovascular 2015

The Antiproliferative Endovascular Era in PAD Treatment: Are we there yet?

Presenter: Danielle R. Bajakian

September 18, 2015

Presentation CICT 2015

Drug Eluting Femoral Stents Where does it fit in my practice?

Presenter: Yazan Khatib

July 31, 2015

Presentation CCVVC 2015

Future Therapeutic Options in the Management of CLI

Presenter: D. Scheinert

June 18, 2015

Presentation ISET 2015

Recanalization of SFA Popliteal Arteries: Flossing and Other Solutions

Presenter: Alan H. Matsumoto

February 02, 2015

Presentation ISET 2015

New Insights from Real-World Femoral-Popliteal Drug-Coated Balloon Treatment: One-Year Results from IN_PACT Global Study, Including Long Lesions

Presenter: Gunnar Tepe

February 02, 2015

Advertisement

Femoral Popliteal DVT

12-Month Results From First-in-Human Randomized Study of Ranger DCB for Femoropopliteal Treatment

High Rate of Amputation and Death after Major Adverse Limb Events (MALE) in Peripheral Artery Disease: Results from COMPASS

Two-year Results from the IN.PACT Global Study

Paclitaxel-Eluting Stent Treatment for PAD: Insights from the Zilver PTX Post-Market Study in Japan

Use of Drug Eluting Stents in the SFA: What are the Current Data, Real World Applications, Upcoming Trials

My most difficult femoropopliteal case: 69 yo female

My Most Difficult Femoropopliteal Case

The Antiproliferative Endovascular Era in PAD Treatment: Are we there yet?

Drug Eluting Femoral Stents Where does it fit in my practice?

Future Therapeutic Options in the Management of CLI

Recanalization of SFA Popliteal Arteries: Flossing and Other Solutions

New Insights from Real-World Femoral-Popliteal Drug-Coated Balloon Treatment: One-Year Results from IN_PACT Global Study, Including Long Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content